Clinical Trial Update: Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating allo stem cell transplant followed by lenalidomide and sirolimus maintenance in high-risk multiple myeloma; study terminated with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Sherif S. Farag | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-12-06